Two weeks of inactivity found to cause impaired glycemic control; may progress patients to type 2 diabetes

Newborns at increased risk for vascular complications, such as hypertension and cardiovascular disease.

A look into health conditions, other than diabetes, that may cause hypoglycemia.

Guest Post by David Kliff, Editor, Diabetic Investor

Whether the toy makers realize it or not, the key to getting their toys played with is to make the toy as easy to use as possible. This ease of use does not just mean things like easy insertion of a sensor, like Dexcom has done with the G6 or Abbott has done with the Libre. It goes beyond not having to calibrate either of these sensors. When it comes to increasing the use of insulin, it means making dosing insulin as “stupid” as possible; take all the decisions out of the hands of the patient.

True or False: there is an antidiabetic medication available on the US market with an indication from the US Food and Drug Administration (FDA) to prevent cardiovascular (CV) disease. Follow the link for the answer.

What percentage of your patients with diabetes would benefit from Real-Time CGM? 0 to 25%, 26% to 50%, 51% to 75%, or 76% to 100%? Follow the link and see how you compare to your colleagues.

In the conclusion of this week's Homerun Slides, the clinical performance of the Eversense CGM System.

High density mapping: GWAS do not inevitably lead to identification of a gene or genes in a given locus associated with disease.The most strongly associated SNPs are often only markers for the functional variant responsible for the observed genetic effect and most associated regions harbor several genes. Therefore, additional fine mapping of the loci in even larger sample sets is often necessary. To do this cost-efficiently a Cardio-Metabochip has been developed for metabolic/cardiovascular gene mapping. This custom-design Illumina Infinium genotyping chip contains ∼200,000 polymorphisms selected to cover association signals from a wide range of metabolic disorders (T2DM, lipid disorders, obesity, and cardiovascular disease), was designed to perform both deep replication of major disease signals and fine mapping of established loci. Meta-analysis of previous GWAS with an additional 22,669 T2DM cases and 58,119 controls genotyped using the Cardio-Metabochip has recently added another eight new loci associated with T2DM in the European population

Heart disease said cause of one on every four deaths in the U.S.

Pancreatic hormones, glucagon and insulin said partially responsible for unintended increase in glucose.